Pelayes/Singh cannula

Pelayes/Singh cannula

[caption id='attachment_1674' align='alignright' width='400' caption='The new 25-gauge cannula from Geuder']The new 25-gauge cannula from Geuder[/caption]

In cooperation with Dr David Pelayes of Argentina and Dr Arun Singh of US, Geuder has developed a new 25-gauge cannula for Fine Needle Aspiration Biopsy (FNAB) of uveal melanoma. A company spokeswoman said a particular feature of the product, in comparison to former standard cannulas, is the surface millimetre markings which facilitate the precise depth penetration into the uveal melanoma. “Besides, the short bevel of the cannula allows full entry of the needle tip into the tumour, so due to the superior cellularity of the biopsy aspirates the diagnostic yield is higher,†she said.
www.geuder.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...